Trinity Biotech Plc - Company Profile
Powered by 
All the sales intelligence you need on Trinity Biotech Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Trinity Biotech Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Trinity Biotech Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on Trinity Biotech Plc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CA2942347C | Grant | Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders | C12N15/85; G01N33/5005; G01N33/564; G01N33/6854 | March 14, 2023 |
| EP3916007A4 | Search Report | VERBESSERTER NACHWEIS VON ANTINUKLEÄREN ANTIKÖRPERN UND DIAGNOSTIKA FÜR SYSTEMISCHE UND NICHT-SYSTEMISCHE AUTOIMMUNERKRANKUNGEN | C12N15/85; G01N33/5005; G01N33/564; G01N33/6854 | December 01, 2021 |
| EP3916007A1 | Application | Verbesserter nachweis von antinukleären antikörpern und diagnostika für systemische und nicht-systemische autoimmunerkrankungen | C12N15/85; G01N33/5005; G01N33/564; G01N33/6854 | December 01, 2021 |
| ES2870592T3 | Grant | Detección mejorada de anticuerpos antinucleares y diagnóstico para trastornos autoinmunes sistémicos y no sistémicos | C12N15/85; G01N33/5005; G01N33/564; G01N33/6854 | October 27, 2021 |
| HUE054419T2 | Application | Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders | C12N15/85; G01N33/5005; G01N33/564; G01N33/6854 | September 28, 2021 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer